Qube Research & Technologies LTD Akero Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$11.38 - $50.33 $1.56 Million - $6.89 Million
136,828 New
136,828 $3.19 Million
Q4 2020

Feb 16, 2021
SELL
$25.12 - $29.89 $458,741 - $545,851
-18,262 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$30.79 - $39.92 $562,286 - $729,019
18,262 New
18,262 $562,000

Others Institutions Holding AKRO

# of Institutions
193
Shares Held
74.6M
Call Options Held
241K
Put Options Held
647K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.62B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email